4 départements de recherche
750 employés
45 nationalités
55 équipes de recherche
16 lauréats ERC
260 publications par an
24000 m² de laboratoires

Soutenez-nous via

Fondation universite de Strasbourg

photo

Chef d'équipe

Izabela SUMARA
izabela.sumara@igbmc.fr
Tel. : +33 (0)3 88 65 33 88
Tel. : +33 (0)3 88 65 35 21

Les chiffres

51 équipes de recherche
138 chercheurs
56 post-doctorants
115 doctorants
164 ingénieurs & techniciens
1 masters
129 administratifs & services généraux 110 personnels ICS

Accès direct

Recrutement

Linking Ubiquitin Signaling To Fragile X Syndrome (Fxs)

Reference : PhD Izabela Sumara

Publication de l'offre : 26 janvier 2018

Fragile X syndrome (FXS) is the most common form of cognitive human disability, for which no efficient therapy exists to date. It is caused by silencing of Fragile X mental retardation protein FMRP, which belongs to the Fragile X-related (FXR) protein family together with FXR1 and FXR2. These proteins are RNA binding proteins that critically control translational processes of hundreds of transcripts. However, their roles beyond RNA regulation remain elusive.

 

We found an unexpected link between FXR proteins and nuclear organization and showed that they regulate assembly of nucleoporins (NUPs) at the nuclear envelope (NE). We further identified the ubiquitin binding protein NICE-4 as a specific partner of FXR proteins that controls their localization to NE. Thus, we have identified the first regulatory factor of the FXR-NUP pathway that links it to ubiquitin signaling. We hypothesize that its misregulation will change differentiation programs and contribute to the pathology of FXS and related human disorders.

 

The aim of this project is to characterize the role of ubiquitin signaling in Fragile X syndrome and related diseases.

Votre candidature

Date limite de candidature : 1 novembre 2018

Imprimer Envoyer

Université de Strasbourg
INSERM
CNRS

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr